Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 106, Issue 19
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Special populations
Original research
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Online download statistics by month:
Online download statistics by month: July 2020 to January 2021
Abstract
Full
Pdf
Jul 2020
83
82
5
Aug 2020
19031
18951
5230
Sep 2020
14894
14841
1847
Oct 2020
13990
13954
1026
Nov 2020
9920
9828
770
Dec 2020
10113
10045
733
Jan 2021
11943
11850
922
Total
79974
79551
10533
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF